1001907-44-3 Usage
Uses
Used in Pharmaceutical and Agrochemical Industries:
1-Boc-azetidine-3-carboxylic acid is utilized as a building block in organic synthesis for the production of various pharmaceuticals and agrochemicals. Its versatility and stability contribute to the development of new and improved compounds with specific therapeutic or pesticidal properties.
Used in Asymmetric Synthesis:
In the field of asymmetric synthesis, 1-Boc-azetidine-3-carboxylic acid serves as a chiral auxiliary. It aids in the synthesis of enantiomerically pure compounds, which is crucial for the production of drugs with targeted effects and reduced side effects. 1-Boc-azetidine-3-carboxy...'s reactivity and stability make it an effective tool for achieving high levels of enantioselectivity in chemical reactions.
Used in Medicinal Research:
1-Boc-azetidine-3-carboxylic acid is employed in medicinal research for the exploration of its potential applications in drug discovery. Its unique structure and properties allow researchers to investigate its interactions with biological targets, potentially leading to the development of new therapeutic agents.
Used in Chemical Research:
In chemical research, 1-Boc-azetidine-3-carboxylic acid is used to study its reactivity and stability, as well as to develop new synthetic methods and strategies. This knowledge can be applied to the synthesis of complex organic molecules and the optimization of existing synthetic routes, ultimately contributing to advancements in the field of chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 1001907-44-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,1,9,0 and 7 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1001907-44:
(9*1)+(8*0)+(7*0)+(6*1)+(5*9)+(4*0)+(3*7)+(2*4)+(1*4)=93
93 % 10 = 3
So 1001907-44-3 is a valid CAS Registry Number.
1001907-44-3Relevant articles and documents
FUSED PYRIMIDINES
-
Page/Page column 151-152, (2010/09/03)
Compounds of formula (I), or an N-oxide, a salt, a tautomer or a stereoisomer of said compound, or a salt of said N-oxide, tautomer or stereoisomer, wherein ring B and the pyrimidine to which it is fused, R4, R5, R6, R7, m and n have the meanings as given in the description and the claims, which are effective inhibitors of the Pi3K/Akt pathway, processes for their production and their use as pharmaceuticals.
FUSED PYRIMIDINES AS AKT INHIBITORS
-
Page/Page column 75, (2010/09/03)
The present invention relates to compounds of formula (I), a N-oxide or tautomer or stereoisomer thereof, or a salt thereof, wherein ring B and the imidazole to which it is fused, R4, R6, R7, R10, m and n have the meanings as given in the description and the claims, which are effective inhibitors of the Pi3K/Akt pathway, processes for their production and their use as pharmaceuticals.
